Clinical Trials Browser

Phase 1/2 × Sitagliptin Phosphate × Clear all

NCT05895201 2024-04-29

High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

Phase 1/2 Withdrawn

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04268563 2021-03-22

Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients

Phase 1/2 Unknown

Infertility, Polycystic Ovary Syndrome